Scientific Program - Stroke
|
Please see below the CONy Scientific Program. Please click on the appropriate section (ordered by ABC) to view the relevant program. Please note that the program and timing is subject to change. To view the program timetable, please click here
|
| Adamantiades-Behçet's disease | The Brain and Mind in Greek Philosophy | Contursi Kindred |
Dementia |
| Epilepsy |
Headache | Multiple Sclerosis | Neuroimmunology |
| Rehabilitation / Sleep | Stroke |
| Section Heads: Natan Bornstein, Israel & Georgios Tsivgoulis, Greece |
|
|||
| 7:00-7:50 | E-poster Guided Tours (Stroke, Parkinson's, Headache, & MS) | ||
| 08:30-10:30 |
NEUROSONOLOGY: ESUS THERAPY
|
||
| Chairs: Georgios Paraskevas, Greece; Rahim Aliyev, Azerbaijan | |||
| 8:00-10:00 | Proposition: Neurosonology is useful in acute ischemic stroke (AIS) management | ||
| Capsule: |
Neuroimaging plays an imporatant role in the assmemnt of acute stroke patients. However, the usefulness of Doppler ultrasound in AIS mangament is still uncertain and will be discussed.
|
||
| 8:00-8:10 | Host: Laszlo Csiba, Hungary | ||
| 8:10-8:25 | Pro: Andrei V. Alexandrov, USA | ||
| 8:25-8:40 | Con: Vasileios-Arsenios Lioutas, USA | ||
| 8:40-9:00 | Discussion and rebuttals | ||
| 9:00-10:00 | Proposition: Patients with embolic stroke of undetermined source (ESUS) need to be anticoagulated | ||
| Capsule: | Many AIS are cryptogenic, and may represent ESUS. ''Silent'' paroxysmal AF may be detected in some by longterm ECG monitoring. Should those with AF shorter than 30'' also be anticoagulated? | ||
| 9:00-9:10 | Host: Miliija Mijajlovic, Serbia | ||
| 9:10-9:25 | Pro: Martin Kohrmann, Germany | ||
| 9:25-9:40 | Con: Natan Bornstein, Israel | ||
| 9:40-10:00 | Discussion and rebuttals | ||
| 10:00-10:15 | Coffee Break | ||
| 10:15-12:10 | THROMBOLYSIS AND THROMBECTOMY: TO WHOM AND WHEN? |
||
| Chairs: Christina Plastir, Greece; Roni Eichel, Israel | |||
| 10:15-11:10 | Proposition: Intravenous thrombolysis is effective in wake-up stroke with normal baseline CT | ||
| Capsule: | Wake-up strokes account for about 20% of AIS and present a therapeutic dilemma. Can a normal CT help in selecting patients for thrombolysis? | ||
| 10:15-10:25 |
Host: Odysseas Kargiotis, Greece
|
||
| 10:25-10:40 |
Pro: Christos Krogias, Germany
|
||
| 10:40-10:55 | Con: Panos Mitsias, Greece |
||
| 10:55-11:10 | Discussion and rebuttals | ||
| 11:10-12:10 | Proposition: Mechanical thrombectomy is effective in M2 occlusions | ||
| Capsule: | Recently thrombectomy was proven to be beneficial in patients with acute major artery (eg M1) occulsions. However, its usefulness in smaller arteries (eg M2) is still uncertain and will be debated. | ||
| 11:10-11:20 |
Host: Georgios Tsivgoulis, Greece
|
||
| 11:20-11:35 |
Pro: Odysseas Kargiotis, Greece
|
||
| 11:35-11:50 |
Con: Vasileios-Arsenios Lioutas, USA
|
||
| 11:50-12:10 | Discussion and rebuttals | ||
| 15:05-17:00 |
STROKE: ROLE OF ANTICOAGULANTS
|
||
| Chair: Joanna Wojczal, Poland | |||
| 15:05-16:00 | Debate: What is the optimal anticoagulation for secondary stroke prevention of NVAF patients with good (>66%) TTR? | ||
| 15:05-15:15 | Host: Martin Kohrmann, Germany | ||
| 15:15-15:30 | NOACs: Laszlo Csiba, Hungary | ||
| 15:30-15:45 | VKA: Safouris Apostolos, Greece | ||
| 15:45-16:00 | Discussion and rebuttals | ||
| 16:00-17:00 | Proposition: Anticoagulation therapy should not be restarted in patients with anticoagulation-related lobar intracerebral hemorrhage | ||
| Capsule: |
Capsule: The current recommendation for patients with NVAF who experienced a lobar hemorrhage while antiaocagulated is to refrain from restarting anticoagulants. Is this policy correct?
|
||
| 16:00-16:10 | Host: David Werring, UK | ||
| 16:10-16:25 | Fact: Edip Gurol, USA | ||
| 16:25-16:40 | Fiction: Jonathan Streifler, Israel | ||
| 16:40-17:00 | Discussion and rebuttals | ||
| 17:00-17:15 | Coffee Break |
| 17:15-19:00 |
STROKE: ROLE OF STATINS
|
| Chairs: Ghassan Balousha, Palestine (TBC); Michael Chopp, USA |
|
| 17:15-18:10 |
Debate: High-dose statins should be administered in all patients with acute large artery atherosclerotic stroke |
| Capsule: |
The risk of intracerebral hemorrhage (ICH) is higher in patients comedicated with statins and SSRI's. Should these drugs be discontinued following ICH?
|
| 17:15-17:25 | Host: Andrei Alexandrov, USA |
| 17:25-17:40 | Pro: Georgios Tsivgoulis, Greece |
| 17:40-17:55 | Con: Christos Krogias, Germany |
| 17:55-18:10 | Discussion and rebuttals |
| 18:10-19:00 |
Debate: Statin pretreatment should be discontinued in patients with acute intracerebral hemorrhage (ICH)
|
| Capsule: | The risk of ICH is higher in patients comedicated with statins. Should these drugs be discontinued following ICH? |
| 18:10-18:20 | Host: Jonathan Streifler, Israel |
| 18:20-18:35 | Pro: David Werring, UK |
| 18:35-18:50 | Con: Edip Gurol, USA |
| 18:50-19:00 |
Discussion and rebuttals |
|
|||
| 8:30-10:30 | PLENARY LECTURES: OPENING SESSION | ||
| Chairs: Amos D. Korczyn, Israel; Konstantinos Vadikolias, Greece | |||
| 8:30-9:30 | Welcome remarks and invitation to CONy 2018 Amos D. Korczyn, Israel; Konstantinos Vadikolias, Greece |
||
| 9:00-9:30 |
The role of medical doctors in society: Consulting the new doctors
Panos Zirogiannis, Greece
|
||
| 9:30-10:00 | Wellness, coaching and medicine - what do they have in common? Ewa Stelmasiak, Poland |
||
| 10:00-10:30 | Preventing Alzheimer's disease by means of natural selection Lloyd A. Demetrius, USA |
||
| 10:30-11:00 | Coffee Break | ||
| 11:00-13:00 | PLENARY LECTURES: BRAIN AND MIND | ||
| Chair: John Tzartos, Greece; Ovidiu Bajenaru, Romania | |||
| 11:00-11:30 |
The hard problem
Antti Revonsuo, Finland
|
||
| 11:30-12:00 | Brain and Mind: Who is the puppet and who the puppeteer? George Paxinos, Australia |
||
| 12:00-12:30 | Medically unexplained symptoms Amos D. Korczyn, Israel |
||
| 12:30-13:00 | Discussion | ||
| 13:00-13:45 | Lunch Break | ||
| 13:45-16:15 | PLENARY LECTURES: UPCOMING THERAPIES | ||
| Chair: Panayiotis Vlamos, Greece; Néstor Gálvez-Jiménez, USA | |||
| 13:45-14:15 | The power of next-generation-sequencing for the diagnosis of neurological disorders Heinz Gabriel, Germany |
||
| 14:15-14:45 | Biological nanoparticles-exosomes: novel restorative therapy for neurologic injury and disease Michael Chopp, USA |
||
| 14:45-15:15 | Stem cells: the disappointments, the hurdles, and the promise Dimitrios Karussis, Israel |
||
| 15:15-15:45 | Secondary stroke prevention 2017: Challenges and future perspectives Natan Bornstein, Israel |
||
| 15:45-16:15 | The new antiparkinson drugs: Are they really better? Laszlo Vecsei, Hungary |
||
| 16:15-16:30 | Coffee Break | ||
| 16:30-18:00 | PLENARY LECTURES | ||
| Chairs: Jozef Opara, Poland; Weidong Le, China | |||
| 16:30-17:00 |
Distance learning in neurology
Morris Freedman, Canada
|
||
| 17:00-17:30 | Pitfalls of systematic reviews and meta-analyses Evangelos Kontopantelis, Greece / UK |
||
| 17:30-18:00 |
Open Access to Research Data
Natalia Manola, Greece
|
||
| 19:00 | Welcome Reception |
||
